Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC), 32714-32715 [E8-12960]
Download as PDF
<![CDATA[
32714
Federal Register / Vol. 73, No. 112 / Tuesday, June 10, 2008 / Notices
EXHIBIT 1.—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Data collection instrument
Number of responses per
respondent
Hours per
response
Total burden
hours
Pre-Training Infection Prevention and Safety Assessment .............................
Post-Training Infection Prevention and Safety Assessment ...........................
Baseline Infection Rate Summary ...................................................................
Follow-up Infection Rate Summary .................................................................
Infection Prevention and Patient Safety Activity Catalogue ............................
Training Evaluation ..........................................................................................
34
136
34
136
136
34
20
5.75
1
1
1
25
30/60
45/60
30/60
40/60
1.00
10/60
340
587
17
91
136
141
Total ..........................................................................................................
136
na
na
1,312
EXHIBIT 2.—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
(hours)
Data collection instrument
Total burden
rate*
Average
hourly wage
burden
Total cost
Pre-Training Infection Prevention and Safety Assessment .............................
Post-Training Infection Prevention and Safety Assessment ...........................
Baseline Infection Rate Summary ...................................................................
Follow-up Infection Rate Summary .................................................................
Infection Prevention and Patient Safety Activity Catalogue ............................
Training Evaluation ..........................................................................................
34
136
34
136
136
34
340
587
17
91
136
141
$41.75
41.75
28.99
28.99
39.02
49.04
$14,195
24,507
493
2,638
5,307
6,915
Total ..........................................................................................................
136
1,312
na
54,055
* Based
on the planned respondents, the average hourly rates are the average of the mean hourly wage estimates for the following occupational groups: epidemiologists, healthcare support aides, medical and health services managers, pharmacists, physicians, physician assistants,
registered nurses, and respiratory therapists. The wage estimates are derived from the National Occupational Employment and Wage Estimates,
Bureau of Labor Statistics, May 2006.
dwashington3 on PRODPC61 with NOTICES
Estimated Annual Costs to the Federal
Government
This data collection effort is one
aspect of a larger effort focused on
reducing healthcare associated
infections, The cost of developing the
data collection instruments by a onetime statistical support task order is
$25,000. The costs of implementing the
data collection instruments and
analyzing and publishing the results are
$108,650 annually. Finally, the
estimated costs for federal staff time for
supporting the common data collection
efforts are $24,000 annually. Thus, the
estimated annual cost to the federal
government is $145,150.
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ health care research, quality
improvement and information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and,
VerDate Aug<31>2005
15:35 Jun 09, 2008
Jkt 211001
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: May 30, 2008.
Carolyn M. Clancy,
Director.
[FR Doc. E8–12768 Filed 6–9–08; 8:45 am]
Time and Date: 1 p.m.—3 p.m., June 10,
2008 (Closed).
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road NE., Mailstop E21,
Atlanta, GA 30333. Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 3, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–12958 Filed 6–9–08; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Establishment of a
Community-Clinical Project 2008–R–09
Correction: This notice was published
in the Federal Register on April 21,
2008, Volume 73, Number 77, page
21355. The aforementioned meeting has
been rescheduled to the following:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Ethics Subcommittee, Advisory
Committee to the Director, Centers for
Disease Control and Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC, announces the
E:\FR\FM\10JNN1.SGM
10JNN1
Federal Register / Vol. 73, No. 112 / Tuesday, June 10, 2008 / Notices
following meeting for the
aforementioned Subcommittee:
Times and Dates: 1 p.m.–6 p.m., June 26,
2008. 8 a.m.–12 p.m., June 27, 2008.
Place: CDC, Thomas R. Harkin Global
Communication Center, 1600 Clifton Road,
Atlanta, GA 30333.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 70 people. To
accommodate public participation in the
meeting, a conference telephone line will be
available. The public is welcome to
participate during the public comment
periods by calling (866) 919–3560 and
entering code 4168828. The public comment
periods are tentatively scheduled for 5:30
p.m.–5:45 p.m. on June 26, and from 11:15
a.m.–11:30 a.m. on June 27. For security
reasons, members of the public interested in
attending the meeting should contact the
person below. The deadline for notification
of attendance is June 20, 2007.
Purpose: The Ethics Subcommittee will
provide counsel to the ACD, CDC, regarding
a broad range of public health ethics
questions and issues arising from programs,
scientists and practitioners.
Matters to Be Discussed: Agenda items will
include the following topics: priorities of the
Advisory Committee to the Director, ethical
guidance for ventilator distribution, ethical
guidance for use of traveler restrictions,
ethical guidance for public health emergency
preparedness and response, and updates on
activities relating to CDC partnerships,
genomics, and shared responsibility for
stockpiling antiviral medications.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact: Drue
Barrett, PhD, Designated Federal Official,
Ethics Subcommittee, CDC, 1600 Clifton
Road, NE., M/S D–50, Atlanta, Georgia
30333. Telephone (404)639–4690. E-mail:
dbarrett@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 30, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–12960 Filed 6–9–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
dwashington3 on PRODPC61 with NOTICES
Food and Drug Administration
Food Protection Task Force
Conference
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
VerDate Aug<31>2005
15:35 Jun 09, 2008
Jkt 211001
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of conference grant funding
for meetings of State Food Protection
Task Forces. The original
announcement of availability of funding
for State Food Safety Task Force
Meetings, published in the Federal
Register June 25, 2004 (69 FR 35651)
and February 4, 2005 (70 FR 6015) as
revised on May 3, 2005 (70 FR 22889).
This revised announcement provides for
a change in the name of the grant
program to align with the FDA Food
Protection Plan and new policies that
apply to the State Food Protection Task
Force Meetings conference Grant
Program. FDA anticipates providing
approximately $160,000 in direct costs
only in support of this program in fiscal
year (FY) 2008. It is anticipated that 32
awards will be made for up to $5,000
per award.
FOR FURTHER INFORMATION CONTACT:
Regarding the administrative and
financial management aspects of
this notice: Gladys M. Bohler,
Grants Management Specialist at
301–827–7168 or by e-mail at
gladys.melendezbohler@fda.hhs.gov
Regarding the programmatic aspects
of this notice: Jennifer Gabb,
(DFSR), Office of Regulatory Affairs,
FDA at 301–827–2899, e-mail:
jennifer.gabb@fda.hhs.gov or access
the Internet at: https://www.fda.gov/
ora/fedlstate/default.htm.
Announcement Type: New limited
competition Request for Applications
(RFA) (R13)
Request for Application Number:
RFA-FD–08–06
Catalog of Federal Domestic
Assistance Number(s): 93.103
Dates: The application receipt date is
July 15, 2008.
Paper Applications will not be
accepted. Applications may be
submitted on or after the opening date
and must be successfully received by
Grants.gov no later than 5 p.m. local
time (of the applicant institution/
organization) on the application
submission/receipt date(s). If an
application is not submitted by the
receipt date(s) and time, the application
may be delayed in the review process or
not reviewed.
The required application, SF 424
(5161) can be completed and submitted
online. The package should be labeled,
‘‘Response to RFA FD–08–006.’’ If you
experience technical difficulties with
your online submission you should
contact Gladys M. Bohler by telephone
at 301–827–7168 or by e-mail at
gladys.melendez-bohler@fda.hhs.gov.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
32715
Please visit Grants.gov to view the full
version of this Request for Applications.
A full version of the RFA can also be
found on the Grants.gov Web site along
with the application package. FDA urges
applicants to read the full version RFA
in its entirety prior to submitting
application packets. A publishing of this
announcement in the Federal Register a
copy of the full version RFA can also be
requested from the ORA and Grants
Management contacts listed in the
following paragraphs.
Funding Opportunity Description
I. Background
The FDA’s Office of Regulatory
Affairs (ORA) is the inspection
component of the FDA and has 1,000
investigators and inspectors who cover
the approximately 95,000 FDA regulated
businesses in the United States and
inspect more than 15,000 facilities a
year. In addition to the standard
inspection program, FDA’s investigators
and inspectors conduct special
investigations, food inspection recall
audits, and perform consumer
complaint inspections and sample
collections.
In the past, FDA has relied on the
States in assisting with the previous
duties through formal contracts,
partnership agreements, and other
informal arrangements. The inspection
demands on both the Agency and the
States are expected to increase.
Accordingly, procedures need to be
reviewed and innovative changes made
that will increase effectiveness,
efficiency, and conserve resources.
Examples of support include providing
effective and efficient compliance of
regulated products and, providing high
quality, science based work that
maximizes consumer protection.
II. Research Objectives
FDA views State based Food
Protection Task Forces as an important
mechanism for providing food safety
and food defense program coordination,
and information exchange within each
State (‘‘Food’’ includes human food and
animal feed and is defined in section
201 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 321 (f))). This
grant announcement is intended to
encourage the development of a Task
Force within each State and to provide
funding for Task Force meetings.
Conference grant funding is available to
States that have an existing Food Safety
and Food Defense Task Force, as well as
to States that are in the process of
developing a new Food Protection Task
Force. State Food Protection Task Force
meetings should foster communication
and cooperation among State, local, and
E:\FR\FM\10JNN1.SGM
10JNN1
]]>Agencies
[Federal Register Volume 73, Number 112 (Tuesday, June 10, 2008)]
[Notices]
[Pages 32714-32715]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-12960]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Ethics Subcommittee, Advisory Committee to the Director, Centers
for Disease Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), CDC, announces the
[[Page 32715]]
following meeting for the aforementioned Subcommittee:
Times and Dates: 1 p.m.-6 p.m., June 26, 2008. 8 a.m.-12 p.m.,
June 27, 2008.
Place: CDC, Thomas R. Harkin Global Communication Center, 1600
Clifton Road, Atlanta, GA 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 70 people. To
accommodate public participation in the meeting, a conference
telephone line will be available. The public is welcome to
participate during the public comment periods by calling (866) 919-
3560 and entering code 4168828. The public comment periods are
tentatively scheduled for 5:30 p.m.-5:45 p.m. on June 26, and from
11:15 a.m.-11:30 a.m. on June 27. For security reasons, members of
the public interested in attending the meeting should contact the
person below. The deadline for notification of attendance is June
20, 2007.
Purpose: The Ethics Subcommittee will provide counsel to the
ACD, CDC, regarding a broad range of public health ethics questions
and issues arising from programs, scientists and practitioners.
Matters to Be Discussed: Agenda items will include the following
topics: priorities of the Advisory Committee to the Director,
ethical guidance for ventilator distribution, ethical guidance for
use of traveler restrictions, ethical guidance for public health
emergency preparedness and response, and updates on activities
relating to CDC partnerships, genomics, and shared responsibility
for stockpiling antiviral medications.
Agenda items are subject to change as priorities dictate.
For Further Information Contact: Drue Barrett, PhD, Designated
Federal Official, Ethics Subcommittee, CDC, 1600 Clifton Road, NE.,
M/S D-50, Atlanta, Georgia 30333. Telephone (404)639-4690. E-mail:
dbarrett@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: May 30, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-12960 Filed 6-9-08; 8:45 am]
BILLING CODE 4163-18-P
